Private equity firm Blackstone Group has put up for sale its 13.09% stake in Indian drug company Emcure Pharmaceuticals. The stake will be sold to rival private equity firm Bain Capital for INR650 crore.
Breaking News
According to Bain Capital, India's slowing down resulted in lack of investment opportunities.
Business process and technology services provider Genpact Ltd said U.S. private equity firm Bain Capital Partners will buy a 30 percent stake in the company from General Atlantic and Oak Hill Capital Partners.
U.S. private equity firm Bain Capital is in advanced talks with the Government of Singapore Investment Corp (GIC) GIC.UL to make a joint bid for a 40 percent stake in IT outsourcing company Genpact (G.N) for $1.5 billion to $2 billion.
Subscribe to VCpost newsletter
Most Popular
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- 3.6 Million Medicare Beneficiaries Could Now Get Wegovy Coverage; Here's How!
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Google's Parent Company Alphabet Approves First-Ever Dividend as Shares Skyrocket
